117 related articles for article (PubMed ID: 9505458)
1. Whooping cough vaccine trial compares British whole cell vaccine and acellular vaccines.
Commun Dis Rep CDR Wkly; 1997 May; 7(21):181. PubMed ID: 9505458
[No Abstract] [Full Text] [Related]
2. Improvements in the control of whooping cough.
Commun Dis Rep CDR Wkly; 1995 Jul; 5(30):143. PubMed ID: 7670582
[No Abstract] [Full Text] [Related]
3. Whooping cough notifications continue to fall: young unimmunised infants remain at highest risk.
Commun Dis Rep CDR Wkly; 1999 Jun; 9(23):201, 204. PubMed ID: 10402757
[No Abstract] [Full Text] [Related]
4. Impact of routine vaccination with a pertussis toxoid vaccine in Denmark.
Hviid A; Stellfeld M; Andersen PH; Wohlfahrt J; Melbye M
Vaccine; 2004 Sep; 22(27-28):3530-4. PubMed ID: 15315832
[TBL] [Abstract][Full Text] [Related]
5. The cost of epidemiological transition: a study of a decrease in pertussis vaccination coverage.
Girard DZ
Health Policy; 2005 Nov; 74(3):287-303. PubMed ID: 15951048
[TBL] [Abstract][Full Text] [Related]
6. Teenagers and newborn babies in England and Wales may get pertussis jab as cases continue to rise.
Gulland A
BMJ; 2012 Sep; 345():e5919. PubMed ID: 22951563
[No Abstract] [Full Text] [Related]
7. Seasonal rise in whooping cough.
Commun Dis Rep CDR Wkly; 1997 Oct; 7(43):381, 384. PubMed ID: 9357133
[No Abstract] [Full Text] [Related]
8. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
Gustafsson L; Hessel L; Storsaeter J; Olin P
Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
[TBL] [Abstract][Full Text] [Related]
9. Acellular pertussis vaccines in Japan: past, present and future.
Watanabe M; Nagai M
Expert Rev Vaccines; 2005 Apr; 4(2):173-84. PubMed ID: 15889991
[TBL] [Abstract][Full Text] [Related]
10. Acellular pertussis vaccines: what lies ahead?
Wiedermann BL
Contemp Pediatr; 1995 Sep; 12(9):25-8, 30, 32 passim. PubMed ID: 10155576
[TBL] [Abstract][Full Text] [Related]
11. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.
Vickers D; Ross AG; Mainar-Jaime RC; Neudorf C; Shah S
CMAJ; 2006 Nov; 175(10):1213-7. PubMed ID: 17098950
[TBL] [Abstract][Full Text] [Related]
12. Pertussis transmission in England and Wales.
Gay NJ; Miller E
Lancet; 2000 Apr; 355(9214):1553-4. PubMed ID: 10801196
[No Abstract] [Full Text] [Related]
13. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
14. Control of whooping cough in New Zealand; slow progress.
Lennon D; Reid S; Holdaway D; Thomas M
N Z Med J; 1995 Dec; 108(1013):495-7. PubMed ID: 8532232
[No Abstract] [Full Text] [Related]
15. Experience with diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine in Japan.
Sato H; Sato Y
Clin Infect Dis; 1999 Jun; 28 Suppl 2():S124-30. PubMed ID: 10447030
[TBL] [Abstract][Full Text] [Related]
16. Indications for acellular pertussis vaccines in adults: the case for selective, rather than universal, recommendations.
Gardner P
Clin Infect Dis; 1999 Jun; 28 Suppl 2():S131-5. PubMed ID: 10447031
[TBL] [Abstract][Full Text] [Related]
17. Absolute and relative efficacy of whole-cell vaccines.
Jafari HS
Dev Biol Stand; 1997; 89():167-70. PubMed ID: 9272347
[No Abstract] [Full Text] [Related]
18. Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany.
Juretzko P; von Kries R; Hermann M; Wirsing von König CH; Weil J; Giani G
Clin Infect Dis; 2002 Jul; 35(2):162-7. PubMed ID: 12087522
[TBL] [Abstract][Full Text] [Related]
19. Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study.
Reynolds E; Walker B; Xing D; Southern J; Asokanathan C; Dagg B; Corbel M; Miller E
Vaccine; 2006 Apr; 24(16):3248-57. PubMed ID: 16480794
[TBL] [Abstract][Full Text] [Related]
20. [Assessment of postvaccinal response in children past pertussis].
Grzybowska K; Przybyszewski M; Banasik M; Płaneta-Małecka I; Zeman K
Wiad Lek; 2006; 59(11-12):819-22. PubMed ID: 17427498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
